All In Biotech

Drug Trial Radar · NCT05171049

A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE

A Multicenter, Randomized, Open-label, Blinded Endpoint Evaluation, Phase 3 Study Comparing the Effect of Abelacimab Relative to Apixaban on Venous Thromboembolism (VTE) Recurrence and Bleeding in Patients With Cancer Associated VTE

Last checked: Nov 19, 2026Latest source record: Feb 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. Randomized with 1,150 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

1,150

Actual

Start

May 5, 2022

Primary completion

Feb 4, 2026

Study completion Feb 4, 2026

Sponsor

Lead sponsor
Anthos Therapeutics, Inc.Industry
Sponsor type
Industry
Collaborators
Novartis Pharmaceuticals
First posted
Dec 28, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 3,multicenter, randomized, open-label, blinded endpoint evaluation study comparing the effect of abelacimab relative to apixaban on venous thromboembolism (VTE) recurrence and bleeding in patients with cancer associated VTE (ASTER)

Conditions

  • Venous Thromboembolism
  • Deep Venous Thrombosis
  • Pulmonary Embolism

Interventions

  • AbelacimabBiological

    Abelacimab 150 mg

  • ApixabanDrug

    Apixaban 10 mg followed by 5 mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to first event of centrally adjudicated VTE recurrenceTime frame: Up to 6 months

Locations

209 sites in 21 countries. Site status is shown where the registry gives one.

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado

  • VA Connecticut Healthcare System

    West Haven, Connecticut

  • Washington DC VAMC

    Washington D.C., District of Columbia

  • University of Miami Health

    Miami, Florida

  • NorthShore University Health System

    Evanston, Illinois

  • University of Kentucky, Markey Cancer Center

    Lexington, Kentucky

  • Brigham and Women's Hospital

    Boston, Massachusetts

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts

  • Henry Ford Health System

    Detroit, Michigan

  • Washington University

    St Louis, Missouri

  • Memorial Sloan Kettering Cancer Center-Middletown

    Middletown, New Jersey

  • Memorial Sloan Kettering Cancer Center-Commack

    Commack, New York

  • Memorial Sloan Kettering Cancer Center-West Harrison

    Harrison, New York

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • Lipson Cancer Institute

    Rochester, New York

  • Duke University Medical Center

    Durham, North Carolina

  • Cleveland Clinic Foundation

    Cleveland, Ohio

  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma

  • University of Pennsylvania - Penn Blood Disorders Center

    Philadelphia, Pennsylvania

  • MD Anderson Cancer Center

    Houston, Texas

  • University of Texas Mays Cancer Center

    San Antonio, Texas

  • Gundersen Health System

    La Crosse, Wisconsin

  • Blood Center of Wisconsin

    Milwaukee, Wisconsin

  • Perth Blood Institute

    Perth, Australia

  • The Alfred Hospital

    Prahran, Australia

  • Blacktown Hospital

    Blacktown, New South Wales, Australia

  • Concord Repatriation General Hospital

    Concord, New South Wales, Australia

  • Westmead Hospital

    Westmead, New South Wales, Australia

  • Box Hill Hospital

    Box Hill, Victoria, Australia

  • Monash Medical Centre Clayton

    Clayton, Victoria, Australia

  • Northern Health

    Epping, Victoria, Australia

  • LKH - Universitätsklinikum Graz

    Graz, Austria

  • LK Wiener Neustadt

    Neustadt, Austria

  • Medical University of Vienna

    Vienna, Austria

  • Queen Elizabeth II Health Sciences Centre

    Nova Scotia, Canada

  • McGill University Health Centre

    Québec, Canada

  • University of Calgary

    Calgary, Alberta, Canada

  • University of Alberta Hospital

    Edmonton, Alberta, Canada

  • Hamilton Health Sciences, Juravinski Hospital and Cancer Centre

    Hamilton, Ontario, Canada

  • Ottawa Hospital

    Ottawa, Ontario, Canada

Showing 40 of 209 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.